news
New US bill wants tighter tracking for supplements
A proposed US bill, the Dietary Supplement Innovation Act, aims to close regulatory gaps for new ingredients. It pushes for clearer tracking and mandatory drug-sponsor engagement, according to FDA practice group co-chair Todd Harrison. This could mean fewer novel ingredients slip into the market without proper oversight.
A proposed US bill, the Dietary Supplement Innovation Act, aims to close regulatory gaps for new ingredients. It pushes for clearer tracking and mandatory drug-sponsor engagement, according to FDA practice group co-chair Todd Harrison. This could mean fewer novel ingredients slip into the market without proper oversight.
The architecture take
Listen, the supplement industry often feels like the wild west, especially with new ingredients hitting the market before anyone really knows what they do. This proposed US bill wants to change that by requiring clearer tracking and more engagement from companies introducing novel ingredients. It's not about making supplements less available, but about making sure someone's actually looking at the data before something shows up in your morning smoothie. I've always thought the 'trust us' model for new compounds was a little thin. This kind of policy push, which is about formalizing the evidence for what you put in your body, just shifts the load from the consumer to the manufacturer. Expect fewer 'breakthrough' ingredients without a paper trail. This is a good thing for your nervous system's peace of mind.